FDA Inspection 1218721 — Wickliffe Pharmaceutical Inc
The FDA completed an inspection of Wickliffe Pharmaceutical Inc on September 15, 2023 in Lexington, KY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 15, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Lexington, KY (United States)